Market Size in 2021 | Market Forecast in 2028 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 2,914.1 million | USD 3,838.7 million | CAGR at 4.7% | 2021 |
FrequentlyAsked Questions
Growing aging populations and changing lifestyles are boosting the rising prevalence of ophthalmological problems, one of the protuberant drivers promoting the growth of the global market for eye allergy therapy.
According to the report, the global eye allergy therapeutics market was worth 2,914.1 (USD million) in 2021 and is predicted to grow to 3,838.7 (USD million) by 2028, with a compound annual growth rate (CAGR) of around 4.7%.
North America is anticipated to dominate the industry globally due to the United States' significant advancements in ophthalmology. This is due to the region's high prevalence of eye allergies, extensive knowledge of the condition, and the presence of substantial factors that have led to the introduction of cutting-edge medications.
Some of the main competitors dominating the global eye allergy therapeutics market include - Allergan Plc, Bausch Health Companies Inc., Novartis AG, Santen Pharmaceutical Co. Ltd., Allergy Therapeutics, and Akorn Inc.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed